GLP-1 RECEPTOR AGONIST TREATMENT IN MORBID OBESITY AND TYPE 2 DIABETES DUE TO PATHOGENIC HOMOZYGOUS MELANOCORTIN-4 RECEPTOR MUTATION: A CASE REPORT

Descargar Publicación
Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study Editorial Overview: “Islet Biology in Type 2 Diabetes”